159 related articles for article (PubMed ID: 32363890)
1. Immune modulating effects of additional supplementation of estradiol combined with testosterone in murine testosterone-deficient NAFLD model.
Okamura T; Hamaguchi M; Bamba R; Nakajima H; Yoshimura Y; Kimura T; Nishida K; Hashimoto Y; Fukuda T; Senmaru T; Fukui M
Am J Physiol Gastrointest Liver Physiol; 2020 Jun; 318(6):G989-G999. PubMed ID: 32363890
[TBL] [Abstract][Full Text] [Related]
2. Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice.
Li Y; Sun JP; Wang J; Lu WH; Xie LY; Lv J; Li HX; Yang SF
Biochem Biophys Res Commun; 2019 Aug; 516(3):858-865. PubMed ID: 31266632
[TBL] [Abstract][Full Text] [Related]
3. Caspase-11 promotes high-fat diet-induced NAFLD by increasing glycolysis, OXPHOS, and pyroptosis in macrophages.
Drummer C; Saaoud F; Jhala NC; Cueto R; Sun Y; Xu K; Shao Y; Lu Y; Shen H; Yang L; Zhou Y; Yu J; Wu S; Snyder NW; Hu W; Zhuo J'; Zhong Y; Jiang X; Wang H; Yang X
Front Immunol; 2023; 14():1113883. PubMed ID: 36776889
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone attenuates hepatic inflammation and fibrosis in phosphatidylethanolamine N-methyltransferase-deficient mice.
van der Veen JN; Lingrell S; Gao X; Quiroga AD; Takawale A; Armstrong EA; Yager JY; Kassiri Z; Lehner R; Vance DE; Jacobs RL
Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(7):G526-38. PubMed ID: 26797396
[TBL] [Abstract][Full Text] [Related]
5. CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease.
Parker R; Weston CJ; Miao Z; Corbett C; Armstrong MJ; Ertl L; Ebsworth K; Walters MJ; Baumart T; Newland D; McMahon J; Zhang P; Singh R; Campbell J; Newsome PN; Charo I; Schall TJ; Adams DH
Am J Physiol Gastrointest Liver Physiol; 2018 Apr; 314(4):G483-G493. PubMed ID: 29420066
[TBL] [Abstract][Full Text] [Related]
6. Group 3 Innate Lymphoid Cells Protect Steatohepatitis From High-Fat Diet Induced Toxicity.
Hamaguchi M; Okamura T; Fukuda T; Nishida K; Yoshimura Y; Hashimoto Y; Ushigome E; Nakanishi N; Majima S; Asano M; Yamazaki M; Takakuwa H; Kita M; Fukui M
Front Immunol; 2021; 12():648754. PubMed ID: 33790913
[No Abstract] [Full Text] [Related]
7. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
8. Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue.
Kudo H; Yata Y; Takahara T; Kawai K; Nakayama Y; Kanayama M; Oya T; Morita S; Sasahara M; Mann DA; Sugiyama T
Liver Int; 2009 Aug; 29(7):988-96. PubMed ID: 19386026
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of estrogen/androgen on the prevention of nonalcoholic fatty liver disease in the male rat.
Zhang H; Liu Y; Wang L; Li Z; Zhang H; Wu J; Rahman N; Guo Y; Li D; Li N; Huhtaniemi I; Tsang SY; Gao GF; Li X
J Lipid Res; 2013 Feb; 54(2):345-57. PubMed ID: 23175777
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of myocardin-related transcription factor A (MRTF-A) knockout on experimental mice with nonalcoholic steatohepatitis induced by high-fat diet.
Zhang L; Li HL; Zhang DD; Cui XC
Hum Exp Toxicol; 2021 Oct; 40(10):1634-1645. PubMed ID: 33779332
[TBL] [Abstract][Full Text] [Related]
11. Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor γ.
Tsujimoto S; Kishina M; Koda M; Yamamoto Y; Tanaka K; Harada Y; Yoshida A; Hisatome I
Int J Mol Med; 2016 Sep; 38(3):721-8. PubMed ID: 27431935
[TBL] [Abstract][Full Text] [Related]
12. Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet.
Kamada Y; Kiso S; Yoshida Y; Chatani N; Kizu T; Hamano M; Tsubakio M; Takemura T; Ezaki H; Hayashi N; Takehara T
Am J Physiol Gastrointest Liver Physiol; 2011 Dec; 301(6):G1031-43. PubMed ID: 21885686
[TBL] [Abstract][Full Text] [Related]
13. Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis.
Vitaglione P; Mazzone G; Lembo V; D'Argenio G; Rossi A; Guido M; Savoia M; Salomone F; Mennella I; De Filippis F; Ercolini D; Caporaso N; Morisco F
J Nutr Sci; 2019; 8():e15. PubMed ID: 31037218
[TBL] [Abstract][Full Text] [Related]
14. Testosterone protects high-fat/low-carbohydrate diet-induced nonalcoholic fatty liver disease in castrated male rats mainly via modulating endoplasmic reticulum stress.
Jia Y; Yee JK; Wang C; Nikolaenko L; Diaz-Arjonilla M; Cohen JN; French SW; Liu PY; Lue Y; Lee WP; Swerdloff RS
Am J Physiol Endocrinol Metab; 2018 Apr; 314(4):E366-E376. PubMed ID: 28928235
[TBL] [Abstract][Full Text] [Related]
15. Secreted modular calcium-binding protein 2 promotes high fat diet (HFD)-induced hepatic steatosis through enhancing lipid deposition, fibrosis and inflammation via targeting TGF-β1.
Yuting Y; Lifeng F; Qiwei H
Biochem Biophys Res Commun; 2019 Jan; 509(1):48-55. PubMed ID: 30581002
[TBL] [Abstract][Full Text] [Related]
16. Nicotinic acetylcholine receptor α7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease.
Li DJ; Liu J; Hua X; Fu H; Huang F; Fei YB; Lu WJ; Shen FM; Wang P
Metabolism; 2018 Feb; 79():52-63. PubMed ID: 29129819
[TBL] [Abstract][Full Text] [Related]
17. The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.
Li X; Wang Z; Klaunig JE
Toxicology; 2019 Mar; 416():1-14. PubMed ID: 30711707
[TBL] [Abstract][Full Text] [Related]
18. Effects of high fructose intake on liver injury progression in high fat diet induced fatty liver disease in ovariectomized female mice.
Ohashi T; Kato M; Yamasaki A; Kuwano A; Suzuki H; Kohjima M; Ogawa Y
Food Chem Toxicol; 2018 Aug; 118():190-197. PubMed ID: 29751074
[TBL] [Abstract][Full Text] [Related]
19. Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice.
Kim KH; Kim SH; Han DH; Jo YS; Lee YH; Lee MS
Sci Rep; 2018 May; 8(1):6789. PubMed ID: 29717162
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic Fatty Liver Disease Demonstrates a Pre-fibrotic and Premalignant Molecular Signature.
Almanza D; Gharaee-Kermani M; Zhilin-Roth A; Rodriguez-Nieves JA; Colaneri C; Riley T; Macoska JA
Dig Dis Sci; 2019 May; 64(5):1257-1269. PubMed ID: 30519850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
